1. Technology Decoding: How does PGT technology lock abnormal chromosomes?
,.The chromosome karyotype of normal men is 46,XY, while the karyotype of patients with super-male syndrome is 47,XYY, which means they have one more Y chromosome than normal men. This abnormal number of chromosomes may lead to abnormal physical development, abnormal behavior and personality tendencies, nervous system abnormalities, and reproductive particularities in patients, placing long-term burdens on the family.
The key to achieving super-heritable gene screening lies in Preimplantation Genetic Testing (PGT) during the third-generation IVF process. Two core technologies play a crucial role in this process.
One of them is PGT-A (Preimplantation Genetic Testing for Anomalies)..For super-male syndrome, PGT-A can clearly identify abnormal embryos with a karyotype of 47,XYY through precise chromosome analysis, thereby directly excluding the possibility of transplantation of such embryos.
Another option is PGT-M (Preimplantation Genetic Testing for Single Gene Disorders).If Hyperploidy Syndrome is associated with certain hereditary genes within a family, PGT-M can effectively screen for related single-gene mutations. This approach allows for a more targeted intervention at the genetic level, thereby providing more accurate protection for families with a history of such conditions.
Using IVF technology to avoid the genetic risk of super-male syndrome requires following scientific and rigorous medical procedures, and every step protects the screening of "healthy embryos".
Using in vitro fertilization technology to mitigate the genetic risks associated with super-ovarian syndrome requires adherence to scientific and rigorous medical procedures. Every step involved in the process is designed to ensure the selection of “healthy embryos”.
The first step is to prepare for the standard IVF cycle..Doctors will formulate an ovulation promotion plan based on the woman's physical condition. After the egg is mature, egg retrieval will be carried out, and the man's sperm will be obtained at the same time. Then in vitro fertilization will be completed in a laboratory environment to cultivate and form early embryos.
The second step is embryo biopsy, which is a crucial stage before screening.When the embryo develops to the blastocyst stage, a professional embryologist will accurately remove a small number of trophoblast cells without damaging the main body of the embryo. These cells will develop into a placenta in the future and will not affect the normal growth and development of the fetus. The removed cells will be used as samples for genetic testing.
The third step is the core genetic testing.Laboratory technicians will use PGT-A or PGT-M technology to test biopsy cells and determine whether the embryo has chromosomal abnormalities related to super-male syndrome through chromosome karyotype analysis or gene sequencing.
.Doctors combined the test results with the female uterine environment to select high-quality embryos with normal chromosome karyotypes (46,XY) for transplantation to ensure that a healthy baby is born to the greatest extent possible.
Although the third-generation IVF technology brings hope to families in need, it is crucial to fully understand the limitations of the technology and related precautions before choosing.
Although third-generation in vitro fertilization technology has brought hope to families in need, it is crucial to fully understand the limitations of this technology and any relevant precautions before making a decision.
,.In addition to family genetic factors, the occurrence of super-male syndrome may also stem from accidental mistakes in cell division in the early stages of the embryo, that is, new mutations. Such emergencies are difficult to fully predict through existing technologies, and there is a very small probability of missed screening.
,.If the family has a family history of over-male syndrome, or if both couples have concerns about reproductive health, priority should be given to going to the Reproductive Genetic Center of a regular hospital. Doctors will use comprehensive genetic assessment and physical examination to determine whether it is suitable for third-generation IVF, and formulate personalized diagnosis and treatment plans to avoid blind decision-making.
,.Through precise screening before embryo implantation, this technology significantly reduces the genetic probability of disease and provides strong support for the breeding of healthy descendants. However, it is important to keep in mind that any medical technology must be used under professional guidance. Both spouses should fully communicate with reproductive medicine and genetics experts and make scientific decisions based on their own circumstances, so that technology can truly become a help in protecting family happiness.